| Child |
0 |
0.98 |
| Pediatric Dermatology |
0 |
1 |
| California |
0 |
0.41 |
| Hospital |
0 |
0.41 |
| Lipids Management |
0 |
0.41 |
| Adolescent Medicine |
0 |
0.99 |
| Juvenile Xanthogranuloma (JXG) |
0 |
0.8 |
| Nodule |
0 |
0.97 |
| Pruritus |
0 |
0.2 |
| Dermatofibroma |
0 |
0.15 |
| Dermoscopy |
0 |
0.1 |
| Femoral |
0 |
0.1 |
| Molluscum Contagiosum |
0 |
0.1 |
| Tumor |
0 |
0.1 |
| Neurofibromatosis Type 1 |
0 |
0.09 |
| Biologic Therapy |
0 |
0.08 |
| Skin and Soft Tissue Infection |
0 |
0.08 |
| Langerhans Cell Histiocytosis |
0 |
0.07 |
| Skin Cancer |
0 |
0.07 |
| Spitz Nevus |
0 |
0.07 |
| Cervical Region |
0 |
0.05 |
| Gluteal Region |
0 |
0.05 |
| Hamartoma |
0 |
0.05 |
| Hand |
0 |
0.05 |
| Histiocytosis |
0 |
0.05 |
| Hypertriglyceridemia |
0 |
0.05 |
| Leukemia |
0 |
0.05 |
| Neurofibromatosis |
0 |
0.05 |
| Nevus |
0 |
0.05 |
| Telangiectasia |
0 |
0.05 |
| Tissue |
0 |
0.05 |
| Viral Infection |
0 |
0.05 |
| Xanthoma |
0 |
0.05 |
| Cardiovascular Risk Management |
0 |
0.04 |
| Melanoma |
0 |
0.04 |